医学
肾脏替代疗法
肝素
血液滤过
随机对照试验
凝血病
交叉研究
滤波器(信号处理)
麻醉
泌尿科
血液透析
外科
安慰剂
替代医学
计算机视觉
病理
计算机科学
作者
Emmett Tsz Yeung Wong,Venetia Ong,Deepa Remani,Weng Kin Wong,Sabrina Wong Peixin Haroon,Titus Lau,Hui‐Qing Nyeo,Amartya Mukhopadhyay,Bee‐Hong Tan,Horng‐Ruey Chua
摘要
Polyethyleneimine-layered membrane with grafted heparin (oXiris) may improve filter life during continuous renal replacement therapy (CRRT) in addition to its immunoadsorptive capability, compared with that of conventional membrane. In this single center, prospective, open-label pilot study, we randomized critically ill patients with bleeding risk who underwent anticoagulation-free CRRT, to commence with oXiris or M150 filter with sequential crossover. We examined the filter life with each circuit and its effect on systemic coagulation parameters. We randomized 11 and nine patients to commence CRRT with oXiris and M150 respectively, with 19 oXiris and 20 M150 filter-circuits in all. Patient profiles in both arms were comparable for illness severity and comorbidities. Median filter lives for oXiris versus M150 circuits were 13 h versus 18 h (p = 0.10). Among 11 patients with paired crossover filters, filter lives for 14 oXiris-M150 circuit pairs were 13 h versus 16 h (p = 0.27), and corresponding transmembrane pressures increased to 111 mmHg versus 75 mmHg by 12 h (p = 0.02). Patients' coagulation parameters were comparable following both filter-circuits. CRRT with oXiris (vs. M150) was independently associated with shorter filter life, adjusted for prescribed dose, vascular access, and coagulopathy. Use of oXiris did not prolong filter life over conventional membrane with no evidence of systemic heparin exposure; significant membrane clogging is observed by 12 h with oXiris.
科研通智能强力驱动
Strongly Powered by AbleSci AI